Helping rural cancer patients manage financial burdens
Official title: Addressing Cancer-Related Financial Toxicity in Rural North Carolina Oncology Care Settings
Run by UNC Lineberger Comprehensive Cancer Center · NCT04931251 · Data updated 2026-05-14
This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.
This study is testing a program that helps cancer patients in rural areas manage their financial struggles by connecting them with resources and support.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 255 (estimated) |
| Sponsor | UNC Lineberger Comprehensive Cancer Center Academic / other |
| Locations | 9 sites (Chapel Hill, North Carolina and 8 other locations) |
| Trial ID | NCT04931251 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 and older with any type of cancer diagnosed within the last 5 years who experience high financial toxicity.
✕Probably not a fit
Patients without a cancer diagnosis or those diagnosed more than 5 years ago without advanced disease will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study evaluates a financial navigation program aimed at reducing the financial toxicity experienced by cancer patients in rural and non-rural oncology settings in North Carolina. It involves screening patients for financial toxicity using the COST measure and enrolling those with moderate to severe financial toxicity into a comprehensive support program. Patients will receive assistance from financial navigators to explore available financial resources and benefits over a series of visits. The study will assess the impact of this intervention on patients' financial burdens and health-related quality of life.
Why it matters
Potential benefit: If successful, this program could significantly alleviate the financial stress associated with cancer treatment for rural patients.
How similar studies have gone: While financial navigation is a growing area of interest, this specific approach targeting rural oncology settings is relatively novel and has not been extensively tested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients 18 years of age and older * Patients with any type of cancer diagnosed within 5 years and/or living with advanced disease * Patients who score 22 or lower on the COST measure indicating high FT * Patients must be able to read and speak English Exclusion Criteria: * Participants without a cancer diagnosis * Patients diagnosed more than 5 years ago without advanced disease * Patients or caregivers under the age of 18 * Patients who do not sign the consent form * Patients who do not complete the baseline COST survey * Patients who cannot read and speak English
Where it's running
-
Pardee UNC Health Care, Pardee Cancer Center
Hendersonville, North Carolina, United States Recruiting -
Carteret Health Care Cancer Center
Morehead City, North Carolina, United States Recruiting -
NC Basnight Cancer Hospital
Chapel Hill, North Carolina, United States Completed -
Novant Health
Charlotte, North Carolina, United States Completed -
Vidant Medical Center, Cancer Center
Greenville, North Carolina, United States Completed -
UNC Lenoir Cancer Care Services
Kinston, North Carolina, United States Completed
Show 3 more locations
-
The Outer Banks Hospital
Nags Head, North Carolina, United States Completed -
Nash UNC Health Care
Rocky Mount, North Carolina, United States Withdrawn -
Wake Forest University Health Sciences
Winston-Salem, North Carolina, United States Completed
Study contacts
- Principal investigator: Stephanie Wheeler, PhD — Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill
- Study coordinator: Michelle L Manning, MPH
- Email: mlmannin@email.unc.edu
- Phone: 919-632-5029
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
TriAdeno and N-803 vaccine in early prostate cancer on active surveillance
A vaccine combo called TriAdeno plus the N-803 drug is being tested to see if it can help slow or stop growth in men with early-stage, low- to intermediate-risk prostate cancer who are being watched rather than treated right away.
-
Using vorolanib for treating advanced kidney cancer
This study is testing if the drug vorolanib can help people with advanced kidney cancer live longer when used as a second treatment option.
-
Biobank for pancreatic adenocarcinoma research
This study is collecting samples and information from people with pancreatic cancer to help find better ways to diagnose and treat the disease.
-
Treatment with STAR0602 for advanced solid tumors
This study is testing a new treatment called STAR0602 to see if it can help people with advanced solid tumors by looking at how safe it is and how well it works.
-
Improving treatment planning for recurrent colorectal cancer using MRI
This study is testing a new way to use MRI scans to help doctors plan better treatments for patients with recurrent colorectal cancer.
-
HR20013 for preventing nausea and vomiting in cancer patients receiving chemotherapy
This real-world study tests whether HR20013 helps prevent nausea and vomiting in adults with cancer who are getting chemotherapy.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.